Neuropilins in Tumor Biology

被引:136
作者
Bagri, Anil [3 ]
Tessier-Lavigne, Marc [2 ]
Watts, Ryan J. [1 ]
机构
[1] Genentech Inc, Neurobiol, San Francisco, CA 94080 USA
[2] Genentech Inc, Res Drug Discovery, San Francisco, CA 94080 USA
[3] Genentech Inc, Tumor Biol & Angiogenesis, San Francisco, CA 94080 USA
关键词
ENDOTHELIAL GROWTH-FACTOR; CARCINOMA-CELLS; CANCER CELLS; SOLUBLE NEUROPILIN-1; ANTITUMOR-ACTIVITY; SEMAPHORIN-III; LUNG-CANCER; IN-VIVO; VEGF; ANGIOGENESIS;
D O I
10.1158/1078-0432.CCR-08-0563
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The neuropilin receptors were first discovered as regulators of nervous system development, acting as semaphorin coreceptors with plexins. Subsequently, the neuropilins were identified as receptors for vascular endothelial growth factor. Since those seminal discoveries, additional ligands that bind neuropilins have been described, and many studies have implicated neuropilins in playing key roles in tumor biology. Recent evidence has shown that manipulating neuropilin function can regulate tumor growth and metastasis through effects on vascular biology in the case of neuropilin-1 and lymphatic biology in the case of neuropilin-2. A direct role for neuropilins within in tumor cells has also been postulated. As data continue to accumulate pointing to a role for neuropilins in cancer, the promise for targeting this pathway is beginning to unfold.
引用
收藏
页码:1860 / 1864
页数:5
相关论文
共 39 条
  • [1] Targeting lymphangiogenesis to prevent tumour metastasis
    Achen, M. G.
    Mann, G. B.
    Stacker, S. A.
    [J]. BRITISH JOURNAL OF CANCER, 2006, 94 (10) : 1355 - 1360
  • [2] Bachelder RE, 2001, CANCER RES, V61, P5736
  • [3] Bachelder RE, 2003, CANCER RES, V63, P5230
  • [4] A peptide corresponding to the neuropilin-1-binding site on VEGF165 induces apoptosis of neuropilin-1-expressing breast tumour cells
    Barr, MP
    Byrne, AM
    Duffy, AM
    Condron, CM
    Devocelle, M
    Harriott, P
    Bouchier-Hayes, DJ
    Harmey, JH
    [J]. BRITISH JOURNAL OF CANCER, 2005, 92 (02) : 328 - 333
  • [5] Targeting endothelial and tumor cells with semaphorins
    Bielenberg, Diane R.
    Klagsbrun, Michael
    [J]. CANCER AND METASTASIS REVIEWS, 2007, 26 (3-4) : 421 - 431
  • [6] Semaphorin 3F, a chemorepulsant for endothelial cells, induces a poorly vascularized, encapsulated, nonmetastatic tumor phenotype
    Bielenberg, DR
    Hida, Y
    Shimizu, A
    Kaipainen, A
    Kreuter, M
    Kim, CC
    Klagsbrun, M
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (09) : 1260 - 1271
  • [7] Blocking neuropilin-2 function inhibits tumor cell metastasis
    Caunt, Maresa
    Mak, Judy
    Liang, Wei-Ching
    Stawicki, Scott
    Pan, Qi
    Tong, Raymond K.
    Kowalski, Joe
    Ho, Calvin
    Reslan, Hani Bou
    Ross, Jed
    Berry, Leanne
    Kasman, Ian
    Zlot, Constance
    Cheng, Zhiyong
    Le Couter, Jennifer
    Filvaroff, Ellen H.
    Plowman, Greg
    Peale, Franklin
    French, Dorothy
    Carano, Richard
    Koch, Alexander W.
    Wu, Yan
    Watts, Ryan J.
    Tessier-Lavigne, Marc
    Bagri, Anil
    [J]. CANCER CELL, 2008, 13 (04) : 331 - 342
  • [8] Neuropilin-2 interacts with VEGFR-2 and VEGFR-3 and promotes human endothelial cell survival and migration
    Favier, Benoit
    Alam, Antoine
    Barron, Pauline
    Bonnin, Jacques
    Laboudie, Patricia
    Fons, Pierre
    Mandron, Marie
    Herault, Jean-Pascal
    Neufeld, Gera
    Savi, Pierre
    Herbert, Jean-Marc
    Bono, Francoise
    [J]. BLOOD, 2006, 108 (04) : 1243 - 1250
  • [9] Angiogenesis as a therapeutic target
    Ferrara, N
    Kerbel, RS
    [J]. NATURE, 2005, 438 (7070) : 967 - 974
  • [10] Identification of a natural soluble neuropilin-1 that binds vascular endothelial growth factor:: In vivo expression and antitumor activity
    Gagnon, ML
    Bielenberg, DR
    Gechtman, Z
    Miao, HQ
    Takashima, S
    Soker, S
    Klagsbrun, M
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (06) : 2573 - 2578